You are here

Research

Targeted RFA for Investigation of iPS and Other Derivation Approaches - 2008

Twenty awards totaling $16.3 million were made for Targeted Investigation of Induced Pluripotent Stem Cells (iPS) and Other Derivation Approaches. These aim to stimulate and support investigations to develop improved methods for deriving pluripotent stem cell lines; defining the reprogramming mechanisms; and comparing the utility of iPS with embryonic and other pluripotent stem cells for use in disease models and potential therapeutic applications.

Planning Grants for Emerging Opportunities and Consortia Development for Stem Cell Research - 2008

On September 19, 2008, the ESSCB funding committee recommended $2 million in awards to 18 institutions. These one-year planning contracts are designed to assist New York state research institutions in the development of research consortia and other emerging opportunities in stem cell research. Funds are provided for planning purposes only; no research activities are funded through these awards.

Investigator Initiated Research Projects and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research - 2008

A total of $53.1 million in Investigator Initiated Research Projects and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research awards were made to stimulate and support scientific investigations on aspects of stem cell biology that will lead to a better understanding of the unique properties of stem cells and allow their use to treat disease. Awards were made to 78 investigators , with a maximum of $240,000 for two-year IDEA proposals and a maximum of $1,080,000 for investigator-initiated projects.

Investigator Initiated Research Projects and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research - 2009

A total of $34.7 million in Investigator Initiated Research Projects (IIRP) and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research awards were made in a second round of funding. These awards will stimulate and support scientific investigations on aspects of stem cell biology that will lead to a better understanding of the unique properties of stem cells and allow their use to treat diseases. 52 awards were made to 49 investigators at 15 institutions across the state.  IIRP awards are for up to $1.08 million over three years and IDEA awards are for up to $330,000 over two years

Targeted Projects in Human Embryonic Stem Cell Research - 2009

Three institutions received awards totaling $2.9 million to support efforts to derive and characterize new human embryonic stem cell lines to: devise novel and improved derivation methods; increase efficiency in the production of new cell lines; standardize protocols to improve comparisons between human embryonic stem cells and induced pluripotent stem cells; and enhance the potential of human embryonic and induced pluripotent stem cells for clinical application.

Empire State Stem Cell Scholars: Fellow-to-Faculty Awards in Stem Cell Research - 2009

Awards were made to three institutions to support Empire State Stem Cell Scholars, for a total of $3.2 million. These scholars are eligible for up to two years of continued postdoctoral training in stem cell-relevant research, followed by up to three years of funding for independent stem cell research at the faculty level.  The awards will enable New York State to attract and retain the most promising and exceptionally talented postdoctoral fellows in the early stages of their careers, then transition them to independent tenure track positions at institutions within New York State.

Consortia to Accelerate Therapeutic Applications of Stem Cells - 2011

The ESSCB's Funding Committee recommended three consortia for awards at a meeting on November 16, 2012. The resulting consortia will accelerate clinical applications of stem cell research for the prevention or treatment of diseases.  These collaborative proposals address unmet medical needs using stem cells as their basis for therapeutic treatments and offer advantages over other alternatives in practice or development.  The total value of these awards is $37.8 million and represents a significant investment by the NYSTEM program in support of stem cell-based therapies.

Investigator Initiated Research Projects and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research - 2011

On May 22 and September 24, 2012, the ESSCB Funding Committee approved another group of Investigator Initiated Research Projects (IIRP) and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research awards.  In this, the third round of NYSTEM's generic funding mechanism, 34 awards were granted with a total value of $24.4 million.

Investigator Initiated Research Projects and Innovative, Developmental or Exploratory Activities in Stem Cell Research - 2013

On February 13, 2014, the Funding Committee of the ESSCB recommended funding for 34 new research awards. On October 31, 2014, the Funding Committee recommended an additional seven research awards. This is the fourth round of NYSTEM's generic funding mechanism.  The 41 new awards are comprised of 15 IDEA awards and 26 IIRP awards, and the total value is $32.2 million.

Consortia to Accelerate Therapeutic Applications of Stem Cells - 2013

On October 31, 2014, the Funding Committee of the ESSCB recommended three more consortia awards for funding. The Consortia mechanism, NYSTEM's premier translational award, will accelerate stem cell-based therapies toward clinical trials.

Investigator Initiated Research Projects (IIRP) and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research (Rd 5) - 2016